The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Incidence of febrile neutropenia and effectiveness of pegfilgrastim prophylaxis in patients with advanced-stage solid tumors receiving chemotherapy.
Jeffrey Crawford
Consultant or Advisory Role - Amgen
Research Funding - Amgen
Maureen Reiner
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Phuong Khanh H. Morrow
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Gary H. Lyman
Research Funding - Amgen